Sun Pharmaceutical (SUNPHARMA.NS) Financial Analysis & Valuation | Quarter Chart
Sun Pharmaceutical (SUNPHARMA.NS)
SUNPHARMA.NSPrice: $19.72
Fair Value: 🔒
🔒score
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central ner... more
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and... more
Description
Shares
| Market Cap | $47.32B | Exchange | NSE |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | IN | CEO | Dilip Shantilal Shanghvi |
| IPO Date | 1996-01-01 | CAGR | 0.2% |
| Employees | 43,000 | Website | www.sunpharma.com |
| Div. Yield | 0.84% | Payout Ratio | 0.11% |
| Buy Back Yield | — | Total Yield | 0.84% |
SUNPHARMA.NS chart loading...
Fundamentals
Technicals
| Enterprise Value | $4151.69B | P/E Ratio | 36.28 |
| Forward P/E | 28.99 | PEG Ratio | 1.53 |
| P/S Ratio | 8.03 | P/B Ratio | 5.63 |
| P/CF Ratio | 98.31 | P/FCF Ratio | 196.24 |
| EPS | $0.54 | EPS Growth 1Y | 4.87% |
| EPS Growth 3Y | 35.52% | EPS Growth 5Y | 294.39% |
| Revenue Growth 1Y | 11.19% | Gross Margin | 0.56% |
| Operating Margin | 0.23% | Profit Margin | 0.2% |
| ROE | 0.15% | ROA | 0.11% |
| ROCE | 0.16% | Current Ratio | 2.82 |
| Quick Ratio | 2.31 | Cash Ratio | 0.51 |
| Debt/Equity | 0.05 | Interest Coverage | 39.99 |
| Altman Z Score | 12.1 | Piotroski Score | 3 |